. 2020 Mar 11;9(4):279–288. doi: 10.1530/EC-20-0009
This work is licensed under a Table 1.
Characteristics of the ADDITION-PRO study population by weekday of examination.
| Monday | Tuesday–Friday | P-value | |
|---|---|---|---|
| n | 199 | 1524 | |
| Men (n (%)) | 100 (50) | 821 (54) | 0.375 |
| Age (years) | 64 (7) | 66 (7) | <0.001 |
| Height (cm) | 170 (9) | 170 (9) | 0.945 |
| BMI (kg/m2) | 26.5 (4.1) | 27.3 (4.6) | 0.020 |
| Waist circumference (cm) | 94.2 (13.1) | 95.5 (13.0) | 0.200 |
| Hip circumference (cm) | 100.6 (8.2) | 101.7 (9.9) | 0.132 |
| Fat percentage | 32.0 (7.6) | 32.0 (8.4) | 0.988 |
| HbA1c (%) | 5.6 (0.4) | 5.7 (0.4) | 0.004 |
| HbA1c (mmol/mol) | 38 (5) | 39 (5) | 0.004 |
| Glucose tolerance status (n (%)) | 0.944 | ||
| i-IFG | 41 (20.6) | 293 (19.2) | – |
| i-IGT | 17 (8.5) | 117 (7.7) | – |
| IFG&IGT | 19 (9.5) | 143 (9.4) | – |
| Screen detected type 2 diabetes | 22 (11.1) | 161 (10.6) | – |
| Overnight fasting (h) | 11.8 (10.6,12.9) | 11.5 (10.3,13.0) | 0.450 |
| Time of fasting sample (h:min) | 08:06 (07:42,08:48) | 08:24 (08:00,08:54) | <0.001 |
| PAEE (kJ/kg/day) | 34.3 (15.7) | 32.3 (15.8) | 0.203 |
| CRF (mL O2/kg/min) | 30.1 (5.3) | 29.9 (5.4) | 0.589 |
| Fasting plasma glucose (mmol/L) | 6.1 (0.7) | 6.0 (0.8) | 0.395 |
| Fasting plasma insulin (pmol/L) | 52.2 (47.3) | 45.4 (32.5) | 0.009 |
| Fasting plasma glucagon (pmol/L) | 11.8 (8.0) | 11.3 (8.1) | 0.394 |
| Fasting plasma GLP-1 (pmol/L) | 11.8 (6.8) | 12.1 (5.9) | 0.479 |
| Fasting plasma GIP (pmol/L) | 9.7 (5.9) | 9.7 (6.1) | 0.952 |
Data are shown as means (s.d.) or median (quartile 1, quartile 3).
CRF, cardiorespiratory fitness; GIP, glucose-dependent insulinotropic polypeptide; GLP-1, glucagon-like peptide 1; IFG, impaired fasting glucose; i-IFG, isolated IFG; IGT, impaired glucose tolerance; i-IGT, isolated IGT; PAEE, physical activity energy expenditure.